Pharmaceutical - Genetics

Filter

Current filters:

Genetics

Popular Filters

Novartis signs genome editing alliances with Intellia Therapeutics and Caribou Biosciences

Novartis signs genome editing alliances with Intellia Therapeutics and Caribou Biosciences

08-01-2015

Swiss drug major Novartis has signed collaboration and licensing agreements with Intellia Therapeutics…

GeneticsLicensingNovartisPharmaceuticalSwitzerland

Pfizer enters race to develop Duchenne muscular dystrophy therapy

Pfizer enters race to develop Duchenne muscular dystrophy therapy

07-01-2015

US pharma giant Pfizer is the latest company to enter the race to develop a therapy for Duchenne muscular…

GeneticsPF-06252616PfizerPharmaceuticalResearchUSA

Horizon Discovery acquires Sage Labs for $48 million

Horizon Discovery acquires Sage Labs for $48 million

29-09-2014

UK-based Horizon Discovery Group has agreed to acquire Sage Labs of the USA for up to $16 million in…

GeneticsHorizon DiscoveryMergers & AcquisitionsPharmaceuticalSage LabsUKUSA

Ipsen’s Dysport next generation shows safety and efficacy in Phase III

Ipsen’s Dysport next generation shows safety and efficacy in Phase III

05-02-2014

French drugmaker Ipsen today announced the results of the international Phase III clinical trial of Dysport…

DysportFranceGeneticsIpsenPharmaceuticalResearch

UCB launches online search for rare phenotypes

UCB launches online search for rare phenotypes

28-01-2014

Belgian drugmaker UCB (Euronext Brussels: UCB) has launched an online search to find rare phenotypes…

GeneticsGlobalPharmaceuticalRare diseasesResearchUCB

Potential Duchenne drug expected to complete phase III trial this year

16-08-2013

Dutch biotech company Prosensa says it has made progress with its Duchenne treatments, with six exon…

drisapersenEuropeGeneticsGlaxoSmithKlinePharmaceuticalProsensaResearch

Genomics England's priorities announced on 65th anniversary of the UK's NHS

05-07-2013

The chief executive of the Association of the British Pharmaceutical Industry (ABPI) has welcomed the…

GeneticsPharmaceutical

Treatment with old drug suramin corrects autism symptoms in mouse model

14-03-2013

Testing a new theory, researchers at the University of California, San Diego School of Medicine have…

GeneticsMetabolicsPharmaceuticalResearch

Ethris enters SNIM modified RNA alliance with Shire

07-01-2013

German biotech firm Ethris GmbH has initiated a research based alliance focused on the development and…

BiotechnologyEthris GmbHGeneticsLicensingPharmaceuticalResearchShire

EU funds Population Genetics in leukemia study consortium

28-05-2012

The largest ever genomic study of relapsed acute lymphoblastic leukemia (ALL), the most common malignant…

FinancialGeneticsOncologyPharmaceuticalPopulation Genetics TechnologiesResearch

Emerging discoveries offer opportunities for uncommon genetic disorders

22-05-2012

Groundbreaking therapies are on the horizon as scientists explore new treatment options for rare genetic…

BiotechnologyGeneticsMarkets & MarketingPharmaceuticalResearch

COMPANY SPOTLIGHT

Menarini

Back to top